BioSpace News Archive

Drug Development

Leeds launches groundbreaking study to spot risks of disease

A groundbreaking study has launched in Leeds to better understand how proteins in people’s blood can help identify the risk of disease and enable health professionals to decide on the right care to prevent it.

January 31, 2019
·
4 min read
ACCURON TECHNOLOGIES SPINS OUT MEDTECH BUSINESS

Accuron Technologies Limited today announced that it will spin out its MedTech business.

January 31, 2019
·
2 min read
Biotech Bay

The Leukemia & Lymphoma Society® Kicks-off Local 2019 Students of the Year Campaign

The Leukemia & Lymphoma Society’s Silicon Valley Chapter has announced the 17 Candidate Teams, comprised of 40 local high school students, who have signed up for Students of the Year® presented by Silicon Valley Bank.

January 31, 2019
·
2 min read
Policy

PCMA Statement on the Administration’s Prescription Drug Rebate Proposed Rule

Drugmakers Set and Raise Prices Unrelated to Rebates

January 31, 2019
·
3 min read
Biotech Bay

Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch

- Double-Digit Increase in Probuphine Shipments -

January 31, 2019
·
9 min read
Hyosung Chairman Cho Hyun-Joon Seeks for New Business Model with MIT

Members of MIT faculty and officials of six global start-ups visited the headquarters of Hyosung in Mapo-gu, Seoul, and held ‘MIT ILP Seminar’ under their industrial liaison program.

January 31, 2019
·
2 min read
Policy

Inotrem Announces an Extension of Its License Agreement for the Biomarker Soluble TREM-1 to Cardiovascular Diseases

Inotrem S.A. announced the signature of an exclusive license agreement with four major research organizations, under which it receives the exclusive worldwide rights for the biomarker soluble TREM-1 in cardiovascular diseases, and in particular acute myocardial infarction.

January 31, 2019
·
2 min read
Takeda Scoops Prestigious Global Top Employers® Award for Second Year Running

Takeda Pharmaceutical Company Limited, announced it has become part of a select group of only 12 to receive global Top Employer® status for 2019.

January 31, 2019
·
4 min read
Policy

SIRAKOSS Receives CE Mark for Osteo3 Synthetic Bone Graft Substitute

Represents New Hope for Repairing Challenging Bone Fractures

January 31, 2019
·
3 min read
Business

Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET

Applied DNA Sciences, Inc., announced it plans to release financial results for its fiscal 2019 first quarter ended December 31, 2018 after market close on Thursday, February 7, 2019.

January 31, 2019
·
2 min read